TLR2 and Alzheimer disease: However, the lesional skin of AD patients expresses significantly decreased levels of TJ proteins as well as AMPs [96, 97], indicating that TLR2 signaling is impaired in the suprabasal layers of the epidermis where these genes are expressed.